Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation
Exercise-AF
1 other identifier
interventional
132
1 country
2
Brief Summary
The main purpose of this project is to evaluate the effects of high-intensity interval training (HIIT) compared to moderate-intensity continuous exercise training (MICE) and standard care on exercise capacity and quality of life in patients with persistent or permanent atrial fibrillation. Positive findings are vitally important for these patients, given the condition's substantial morbidity, mortality and high economic costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Jan 2019
Longer than P75 for not_applicable atrial-fibrillation
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2018
CompletedFirst Posted
Study publicly available on registry
January 12, 2018
CompletedStudy Start
First participant enrolled
January 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2037
March 11, 2026
March 1, 2026
8.9 years
January 4, 2018
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in quality of life measured by the physical component summary (PCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36).
Changes in quality of life measured by the physical component summary (PCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36) from baseline to 12 weeks.
baseline to 12 weeks
Changes in exercise capacity measured by VO2peak on a symptom-limited cardiopulmonary exercise test (CPET).
Changes in exercise capacity measured by VO2peak on a symptom-limited cardiopulmonary exercise test (CPET) from baseline to 12 weeks.
baseline to 12 weeks
Secondary Outcomes (11)
Changes atrial fibrillation specific quality of life measured by the Atrial Fibrillation Effect on Quality of Life Questionnaire (AFEQT).
baseline to 12 weeks
Changes atrial fibrillation specific quality of life measured by the University of Toronto Atrial Fibrillation Severity Scale (AFSS).
baseline to 12 weeks
Changes in symptom burden measured by the Canadian Cardiovascular Society Severity of Atrial Fibrillation Scale.
baseline to 12 weeks
Changes in quality of life measured by the mental component summary (MCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36).
baseline to 12 weeks
Changes in heart rate control measured by 24-hour Holter ECG recordings and ECG recordings at each CPET.
baseline to 12 weeks
- +6 more secondary outcomes
Study Arms (3)
standard care
NO INTERVENTIONParticipants do not participate in a on site structured exercise training program.
standard care + MICE
EXPERIMENTALstandard care + moderate-intensity continuous exercise training (MICE)
standard care + HIIT
EXPERIMENTALstandard care + high-intensity interval training (HIIT)
Interventions
Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.
Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.
Eligibility Criteria
You may qualify if:
- persistent or permanent atrial fibrillation;
- rate controlled with a resting ventricular rate of equal to or less than 100 bpm;
- able to perform a symptom-limited exercise test;
- at least 40 years of age (i.e. participants must be 40 years or older);
You may not qualify if:
- currently participating in routine exercise training (more than two times per week);
- unstable angina;
- diagnosed severe mitral or aortic stenosis;
- diagnosed hypertrophic obstructive cardiomyopathy with significant obstruction;
- pregnant, lactating or planning to become pregnant during the study period;
- unable to provide written, informed consent, or
- unwilling or unable to return for follow up at week 12.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
London Health Sciences Network
London, Ontario, Canada
University of Ottawa Heart Insititue
Ottawa, Ontario, K1Y 4W7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer L Reed, PhD
Ottawa Heart Institute Research Corporation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2018
First Posted
January 12, 2018
Study Start
January 23, 2019
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2037
Last Updated
March 11, 2026
Record last verified: 2026-03